Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non–small-cell lung cancer and a performance status of 2
R Lilenbaum, R Axelrod, S Thomas… - Journal of Clinical …, 2008 - ascopubs.org
Purpose A multicenter randomized phase II trial to evaluate two treatment strategies in the
first-line management of advanced non–small-cell lung cancer (NSCLC) patients with a …
first-line management of advanced non–small-cell lung cancer (NSCLC) patients with a …
Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2
R Lilenbaum, R Axelrod, S Thomas… - Journal of clinical …, 2008 - pubmed.ncbi.nlm.nih.gov
Purpose A multicenter randomized phase II trial to evaluate two treatment strategies in the
first-line management of advanced non-small-cell lung cancer (NSCLC) patients with a …
first-line management of advanced non-small-cell lung cancer (NSCLC) patients with a …
Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2
R Lilenbaum, R Axelrod, S Thomas, A Dowlati… - Journal of Clinical …, 2008 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> A multicenter randomized phase II
trial to evaluate two treatment strategies in the first-line management of advanced non–small …
trial to evaluate two treatment strategies in the first-line management of advanced non–small …
Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2.
R Lilenbaum, R Axelrod, S Thomas… - Journal of Clinical …, 2008 - europepmc.org
Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced
non-small-cell lung cancer and a performance status of 2. - Abstract - Europe PMC Sign in …
non-small-cell lung cancer and a performance status of 2. - Abstract - Europe PMC Sign in …
[引用][C] Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non-Small-Cell Lung Cancer and a Performance Status of 2
R LILENBAUM, R AXELROD… - Journal of clinical …, 2008 - pascal-francis.inist.fr
Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced
Non-Small-Cell Lung Cancer and a Performance Status of 2 CNRS Inist Pascal-Francis CNRS …
Non-Small-Cell Lung Cancer and a Performance Status of 2 CNRS Inist Pascal-Francis CNRS …